Dr. Dileep Yavagal Receives Lifetime Achievement Award at AAN 2026

By: Kai Hill | May 01, 2026 | 7 min. read |

The University of Miami Miller School of Medicine neurologist is honored for decades of leadership advancing mechanical thrombectomy and expanding equitable stroke care worldwide.

Illustration of man holding his head in pain

Dileep Yavagal, M.D., chief of interventional neurology and professor of clinical neurology and neurological surgery at the University of Miami Miller School of Medicine, received a Lifetime Achievement Award at the 2026 American Academy of Neurology (AAN) Annual Meeting

The award recognizes his decades‑long contributions to transforming stroke treatment and expanding access to life‑saving care across the United States and around the world.

“Stroke is the second leading cause of death and main cause of permanent adult disability worldwide,” said Jose Romano, M.D., professor and chair of the Department of Neurology at the Miller School. “Dr. Yavagal’s leadership of the global initiative Mission Thrombectomy has made it possible for individuals in middle and lower income countries to afford themselves of this powerful and effective treatment, improving outcomes and saving lives.”

Honoring a Career That Transformed Acute Stroke Care

The award, presented by the Association of Indian American Neurologists (AINA) in collaboration with the American Brain Foundation, honors Dr. Yavagal’s leadership in establishing mechanical thrombectomy as a standard of care for acute ischemic stroke, as well as his sustained efforts to address deep inequities in who receives that care.

Upon receiving the award, Dr. Yavagal reflected on both the honor and the responsibility it represents.

“Receiving this Lifetime Achievement Award is deeply humbling,” said Dr. Yavagal. “It reflects the work of many collaborators, mentors and trainees who share a commitment to ensuring that where you live — or what resources you have — does not determine whether you survive a stroke with your independence intact.”

Mission Thrombectomy and Expanding Global Access

Dr. Yavagal is a founding member and past president of the Society of Vascular and Interventional Neurology (SVIN). His work on landmark clinical trials, including SWIFT PRIME, helped demonstrate the dramatic benefit of mechanical thrombectomy for patients with large‑vessel occlusion stroke, reshaping treatment guidelines worldwide.

While those trials established what was medically possible, much of Dr. Yavagal’s subsequent research and global collaboration has focused on who actually benefits from those advances. As founder of Mission Thrombectomy, a global initiative now active in more than 90 countries, he has taken a public‑health approach to stroke care by combining data, training, advocacy and systems design to improve access in resource‑limited settings.

Dr. Dileep Yavagal and Dr. Jose Romano stand side by side in a large conference room, wearing business attire, with other attendees and meeting space visible in the background. — Dr. Yavagal (left) with Dr. Jose Romano, professor and chair of the Miller School’s Department of Neurology.

One pillar of that work has been innovation aimed at affordability. Dr. Yavagal recently led the GRASSROOT trial, a multicenter study conducted across eight stroke centers in India that evaluated a locally manufactured, lower‑cost stent retriever for mechanical thrombectomy. The trial demonstrated high rates of successful clot removal and low complication rates, providing evidence that high‑quality endovascular stroke care can be delivered effectively in low‑ and middle‑income countries when paired with optimized workflows and training.

The findings carry major implications for global health, where the high cost of single‑use thrombectomy devices has long been a barrier to adoption. By showing that cost‑conscious technology can achieve strong clinical outcomes, Dr. Yavagal’s work has helped pave a pathway toward sustainable stroke systems in countries with limited resources.

Addressing Rural Stroke Disparities in the United States

At the same time, Dr. Yavagal has brought similar rigor to understanding disparities closer to home. In a large U.S. study of more than 24,000 patients using the national Get With The Guidelines®-Stroke registry, he and colleagues found that patients living in rural areas are 15 percent less likely to receive mechanical thrombectomy than urban patients, even after accounting for stroke severity, demographics and social determinants of health.

The research highlighted how geography, hospital resources and transfer patterns continue to shape outcomes for patients with the most severe strokes. While rural hospitals often recognize stroke quickly and initiate transfers appropriately, limited access to thrombectomy‑capable centers and specialized personnel remains a significant barrier.

“These are not theoretical gaps. They translate directly into disability and loss of independence for patients,” Dr. Yavagal has said of rural stroke disparities.

His work has helped frame rural America as a critical frontier for stroke system redesign, emphasizing the need for regional planning, telestroke integration and investment in transfer networks.

A Legacy of Mentorship and Public‑Health Leadership

Mentorship and education are central to Dr. Yavagal’s legacy as well. Over the course of his career, he has trained dozens of residents and fellows who now lead stroke and interventional neurology programs across the U.S. and internationally. Many continue the work of Mission Thrombectomy in their own regions, extending the impact of his vision.

Born and trained in India, Dr. Yavagal has maintained strong ties to the country through teaching, research collaboration and capacity‑building efforts. He has frequently credited the late Ralph L. Sacco, M.D., former chair of neurology at the Miller School, as a formative influence in shaping his public‑health approach to stroke.